Skip to main content

MARSHALL WACE, LLP

Position in BCAB — BioAtla, Inc.

CIK 1318757 LONDON, X0

Position in BCAB

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$44,697
-$461,720 QoQ
Shares Held
277,630
-68.9% QoQ
Ownership
16.7%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BCAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in BCAB

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $44,697 277,630
2025-12-31 $506,417 891,580
2025-06-30 $32,013 80,842
2025-03-31 $29,958 86,335
2024-12-31 $220,472 373,051
2024-09-30 $768,220 436,489
2023-12-31 $111,642 45,383
2023-03-31 $765,571 285,661
2022-12-31 $316,816 38,402
2022-06-30 $155,487 54,557
2022-03-31 $445,720 89,144
2021-12-31 $611,219 31,137